Key Figures

Corporate / Key Figures

Key Figures

In millions of euros	2006	2007	2008
Net sales	178.3	185.3	168.4
Current EBITDA ⁽¹⁾ ⁽²⁾ as a percentage of net sales	21.9 12.3%	26.8 14.5%	19.3 11.5 %
Current operating income ⁽²⁾ as a percentage of net sales	7.9 4.4%	12.0 6.5%	4.6 2.7 %
Of which Pharma Synthesis as a percentage of net sales	7.4 6.7%	7.3 6.7%	5.3 5.2 %
Of which Fine Speciality Chemicals as a percentage of net sales	0.5 0.7%	4.7 6.2%	(0.7) (1.0 %)
Net profit	1.2	2.7	(0.9)
Net debt	79.0	70.1	62.4
Equity	69.1	75.3	73.7

(1) EBITDA is defined as the sum of current operating profit, depreciation and provisions.
(2) including Research Credit Tax previously recorded as a reduction in tax expenses.

Sales by Market (As of 31st Dec. 2008)

Sales by Region (As of 31st Dec. 2008)